$NEWT
NewtekOne, Inc. Stock $newt

$newt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000158798724000054 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$59.68M	$58.48M	$203.7M
YoY Change	38.92%	94.7%	42.29%
Cost Of Revenue	$4.846M	$4.168M	$18.33M
YoY Change	7.59%
Gross Profit	$54.83M	$54.31M	$185.4M
YoY Change	42.59%
Gross Profit Margin	91.88%	92.87%	91.0%
Selling, General & Admin	$32.37M	$25.87M	$107.5M
YoY Change	7.85%	32.52%	63.6%
% of Gross Profit	59.04%	47.62%	58.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$532.0K	$613.0K	$2.884M
YoY Change	-39.06%	956.9%	1106.69%
% of Gross Profit	0.97%	1.13%	1.56%
Operating Expenses	$36.31M	$30.74M	$124.7M
YoY Change	4.67%	57.05%	89.01%
Operating Profit	$18.52M	$23.57M	$60.66M
YoY Change	392.37%
Interest Expense	$18.16M	-$18.07M	-$67.74M
YoY Change	28.51%	182.58%	78.38%
% of Operating Profit	98.07%	-76.66%	-111.68%
Other Income/Expense, Net	$12.74M	$12.75M	$56.07M
YoY Change	-18.94%	-302.8%	-967.37%
Pretax Income	$13.10M	$17.98M	$48.71M
YoY Change	91.09%	-909.36%	50.76%
Income Tax	$3.449M	$4.623M	$5.748M
% Of Pretax Income	26.33%	25.71%	11.8%
Net Earnings	$9.650M	$12.96M	$41.51M
YoY Change	-17.65%	-683.08%	28.47%
Net Earnings / Revenue	16.17%	22.15%	20.38%
Basic Earnings Per Share	$0.38		$1.89
Diluted Earnings Per Share	$0.38	$0.53	$1.70
COMMON SHARES
Basic Shares Outstanding	24.71M shares	24.65M shares	24.26M shares
Diluted Shares Outstanding	24.36M shares		24.35M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$191.3M	$153.1M	$153.1M
YoY Change	-16.83%	185.12%	185.12%
Cash & Equivalents	$163.2M	$139.2M	$139.2M
Short-Term Investments	$28.13M	$32.17M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$184.3M	$215.3M	$215.3M
YoY Change	11.06%	291.27%	291.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.193M	$5.701M	$5.701M
YoY Change	-30.69%	-12.08%	-12.08%
Goodwill	$25.89M	$25.89M
YoY Change	22.16%
Intangibles
YoY Change
Long-Term Investments	$767.0M	$718.4M	$718.4M
YoY Change	29.55%	36.63%	36.63%
Other Assets	$38.48M	$31.38M	$31.38M
YoY Change	-52.4%	-56.36%	-56.36%
Total Long-Term Assets	$1.325B	$1.207B	$1.207B
YoY Change	22.28%	27.9%	27.9%
TOTAL ASSETS
Total Short-Term Assets	$184.3M	$215.3M	$215.3M
Total Long-Term Assets	$1.325B	$1.207B	$1.207B
Total Assets	$1.510B	$1.422B	$1.422B
YoY Change	20.79%	42.41%	42.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.99M	$35.59M	$35.59M
YoY Change	-7.23%	76.07%	76.07%
Accrued Expenses	$6.344M	$6.952M	$6.952M
YoY Change	-30.62%	-12.81%	-12.81%
Deferred Revenue
YoY Change
Short-Term Debt	$512.9M	$463.5M	$463.5M
YoY Change	41.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$593.0M	$534.6M	$534.6M
YoY Change	32.92%	722.21%	722.21%
LONG-TERM LIABILITIES
Long-Term Debt	$662.5M	$644.1M	$644.1M
YoY Change	13.93%	19.43%	19.43%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$662.5M	$644.1M	$644.1M
YoY Change	13.81%	19.43%	19.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$593.0M	$534.6M	$534.6M
Total Long-Term Liabilities	$662.5M	$644.1M	$644.1M
Total Liabilities	$1.255B	$1.179B	$1.179B
YoY Change	21.69%	89.04%	89.04%
SHAREHOLDERS EQUITY
Retained Earnings	$32.61M	$28.05M
YoY Change	362.76%	36.02%
Common Stock	$493.0K	$492.0K
YoY Change	0.41%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$254.1M	$243.7M	$243.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.510B	$1.422B	$1.422B
YoY Change	20.79%	42.41%	42.41%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$9.650M	$12.96M	$41.51M
YoY Change	-17.65%	-683.08%	28.47%
Depreciation, Depletion And Amortization	$532.0K	$613.0K	$2.884M
YoY Change	-39.06%	956.9%	1106.69%
Cash From Operating Activities	-$38.67M	-$19.94M	-$114.3M
YoY Change	-66.76%	-130.59%	83.18%
INVESTING ACTIVITIES
Capital Expenditures	$57.00K	$158.0K	$458.0K
YoY Change	-65.45%		4063.64%
Acquisitions	$0.00		-$11.14M
YoY Change	-100.0%
Other Investing Activities	-$43.75M	-$49.08M	-$171.8M
YoY Change	84.33%
Cash From Investing Activities	-$43.81M	-$49.24M	-$172.2M
YoY Change	83.3%		1565672.73%
FINANCING ACTIVITIES
Cash Dividend Paid	$4.771M		$14.15M
YoY Change			-78.08%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$61.68M	29.47M	345.0M
YoY Change	-67.0%	-235.82%	29259.49%
NET CHANGE
Cash From Operating Activities	-$38.67M	-19.94M	-114.3M
Cash From Investing Activities	-$43.81M	-49.24M	-172.2M
Cash From Financing Activities	$61.68M	29.47M	345.0M
Net Change In Cash	-$20.80M	-39.70M	58.40M
YoY Change	-144.6%	-191.32%	-195.34%
FREE CASH FLOW
Cash From Operating Activities	-$38.67M	-$19.94M	-$114.3M
Capital Expenditures	$57.00K	$158.0K	$458.0K
Free Cash Flow	-$38.73M	-$20.10M	-$114.8M
YoY Change	-66.76%	-130.84%	83.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001587987
CY2023	us-gaap	Interest Expense Customer Deposits InterestExpenseCustomerDeposits	15849000	usd
CY2022	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	-26504000	usd
CY2021	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	11477000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186860000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#DepreciationDepletionAndAmortization
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilities
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	814-01035
CY2023	dei	Entity Registrant Name EntityRegistrantName	NEWTEKONE, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3755188
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4800 T Rex Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 120
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	356-9500
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	365700000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24708771	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	49
CY2023	dei	Auditor Name AuditorName	RSM US LLP
CY2023	dei	Auditor Location AuditorLocation	Hartford, Connecticut
CY2023Q4	us-gaap	Cash Cash	15398000	usd
CY2022Q4	us-gaap	Cash Cash	53692000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	30919000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	71914000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	137689000	usd
CY2022Q4	us-gaap	Due From Banks DueFromBanks	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184006000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125606000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	32171000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2023Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	118867000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	19171000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	56607000	usd
CY2022Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	505268000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	0	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	3635000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	0	usd
CY2023Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	62230000	usd
CY2022Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	0	usd
CY2023Q4	newt	Joint Ventures Amortized Cost JointVenturesAmortizedCost	37864000	usd
CY2022Q4	newt	Joint Ventures Amortized Cost JointVenturesAmortizedCost	23314000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	30120000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5701000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6484000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5230000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Servicing Asset ServicingAsset	39725000	usd
CY2022Q4	us-gaap	Servicing Asset ServicingAsset	30268000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	56102000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	28506000	usd
CY2023Q4	us-gaap	Assets Assets	1429513000	usd
CY2022Q4	us-gaap	Assets Assets	998902000	usd
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	10053000	usd
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	0	usd
CY2023Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	453452000	usd
CY2022Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	0	usd
CY2023Q4	us-gaap	Deposits Deposits	463505000	usd
CY2022Q4	us-gaap	Deposits Deposits	0	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	644122000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	539326000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4792000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6952000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7973000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	19194000	usd
CY2023Q4	newt	Due To Participants DueToParticipants	23796000	usd
CY2022Q4	newt	Due To Participants DueToParticipants	35627000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	37300000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	21424000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1180467000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	623544000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	19738000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24680000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24680000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24609000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24609000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	492000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	492000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200913000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	354243000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	28051000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	20623000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-148000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	249046000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	375358000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1429513000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	998902000	usd
CY2023	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	1518000	usd
CY2022	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	0	usd
CY2021	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	0	usd
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	84001000	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	35696000	usd
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	25951000	usd
CY2023	newt	Interest And Fee Income Paycheck Protection Program Loans InterestAndFeeIncomePaycheckProtectionProgramLoans	0	usd
CY2022	newt	Interest And Fee Income Paycheck Protection Program Loans InterestAndFeeIncomePaycheckProtectionProgramLoans	0	usd
CY2021	newt	Interest And Fee Income Paycheck Protection Program Loans InterestAndFeeIncomePaycheckProtectionProgramLoans	49989000	usd
CY2023	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	0	usd
CY2022	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	2921000	usd
CY2021	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	3026000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	8854000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	94373000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	38617000	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	78966000	usd
CY2022	us-gaap	Interest Expense Customer Deposits InterestExpenseCustomerDeposits	0	usd
CY2021	us-gaap	Interest Expense Customer Deposits InterestExpenseCustomerDeposits	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	67739000	usd
CY2022	us-gaap	Interest Expense InterestExpense	26325000	usd
CY2021	us-gaap	Interest Expense InterestExpense	20515000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26634000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12292000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	58451000	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	11704000	usd
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2021	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2023	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	14930000	usd
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12292000	usd
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	58451000	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1757000	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	24657000	usd
CY2021	us-gaap	Investment Income Dividend InvestmentIncomeDividend	9896000	usd
CY2023	newt	Loan Servicing Asset Revaluation LoanServicingAssetRevaluation	-3549000	usd
CY2022	newt	Loan Servicing Asset Revaluation LoanServicingAssetRevaluation	-10095000	usd
CY2021	newt	Loan Servicing Asset Revaluation LoanServicingAssetRevaluation	-6778000	usd
CY2023	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	50734000	usd
CY2022	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	56901000	usd
CY2021	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	53113000	usd
CY2023	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	18008000	usd
CY2023	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	24916000	usd
CY2022	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	0	usd
CY2021	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	0	usd
CY2023	newt	Electronic Payment Processing Income ElectronicPaymentProcessingIncome	42855000	usd
CY2022	newt	Electronic Payment Processing Income ElectronicPaymentProcessingIncome	0	usd
CY2021	newt	Electronic Payment Processing Income ElectronicPaymentProcessingIncome	0	usd
CY2022	us-gaap	Noninterest Income Other NoninterestIncomeOther	34221000	usd
CY2021	us-gaap	Noninterest Income Other NoninterestIncomeOther	10295000	usd
CY2021	us-gaap	Noninterest Income NoninterestIncome	89310000	usd
CY2023	newt	Electronic Payment Processing Expense ElectronicPaymentProcessingExpense	18327000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	13077000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	7134000	usd
CY2023	newt	Loan Processing Fee Other LoanProcessingFeeOther	9433000	usd
CY2022	newt	Loan Processing Fee Other LoanProcessingFeeOther	30746000	usd
CY2021	newt	Loan Processing Fee Other LoanProcessingFeeOther	29506000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2884000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	239000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	304000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-271000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-417000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1552000	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	22357000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	7673000	usd
CY2023	us-gaap	Noninterest Expense NoninterestExpense	146329000	usd
CY2022	us-gaap	Noninterest Expense NoninterestExpense	66395000	usd
CY2021	us-gaap	Noninterest Expense NoninterestExpense	62292000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	45373000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	38775000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	85469000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1956000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6464000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1327000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	32311000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	84142000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.88
CY2022	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	1.34	usd
CY2021	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	3.69	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	47329000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	32311000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-201000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-201000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-53000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-148000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	47181000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32311000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	84142000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2828000	usd
CY2023	us-gaap	Dividends Dividends	0	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	534000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	56000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	507000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	17463000	usd
CY2023	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	12.27
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1454000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	47329000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-148000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	249046000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	403887000	usd
CY2022	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1614000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2511000	usd
CY2022	us-gaap	Dividends Dividends	0	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	826000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2019000	usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	286000	shares
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	66158000	usd
CY2022	newt	Adjustments To Additional Paid In Capital Ric Tax Reclassifications AdjustmentsToAdditionalPaidInCapitalRICTaxReclassifications	0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	84142000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	-6476000	usd
CY2022	us-gaap	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	57346000	usd
CY2022	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	-18559000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	47329000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	32311000	usd
CY2023	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2022	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2021	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-1266000	usd
CY2023	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	18008000	usd
CY2022	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	-26504000	usd
CY2021	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	11477000	usd
CY2023	newt	Unrealized Gain Loss On Servicing Assets UnrealizedGainLossOnServicingAssets	-3549000	usd
CY2022	newt	Unrealized Gain Loss On Servicing Assets UnrealizedGainLossOnServicingAssets	-10095000	usd
CY2021	newt	Unrealized Gain Loss On Servicing Assets UnrealizedGainLossOnServicingAssets	-6778000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-699000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	183000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-183000	usd
CY2023	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	50734000	usd
CY2022	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	56901000	usd
CY2021	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	53113000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	675000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-271000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-417000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1552000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4052000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2494000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2654000	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	11704000	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3637000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	397000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2828000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4800000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6464000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1327000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2884000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	239000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	304000	usd
CY2023	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	695461000	usd
CY2022	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	691219000	usd
CY2021	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	1203475000	usd
CY2023	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	0	usd
CY2022	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	2404000	usd
CY2021	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	9096000	usd
CY2023	newt	Proceeds From Sale Of Loans ProceedsFromSaleOfLoans	0	usd
CY2022	newt	Proceeds From Sale Of Loans ProceedsFromSaleOfLoans	0	usd
CY2021	newt	Proceeds From Sale Of Loans ProceedsFromSaleOfLoans	5394000	usd
CY2023	newt	Payments For Funding Of Investment Operating Activity PaymentsForFundingOfInvestmentOperatingActivity	783035000	usd
CY2022	newt	Payments For Funding Of Investment Operating Activity PaymentsForFundingOfInvestmentOperatingActivity	775577000	usd
CY2021	newt	Payments For Funding Of Investment Operating Activity PaymentsForFundingOfInvestmentOperatingActivity	1289572000	usd
CY2023	newt	Proceeds From Principal Received On Loans Held For Sale ProceedsFromPrincipalReceivedOnLoansHeldForSale	12235000	usd
CY2022	newt	Proceeds From Principal Received On Loans Held For Sale ProceedsFromPrincipalReceivedOnLoansHeldForSale	74287000	usd
CY2021	newt	Proceeds From Principal Received On Loans Held For Sale ProceedsFromPrincipalReceivedOnLoansHeldForSale	77070000	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	27167000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	48709000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	34856000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3257000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2851000	usd
CY2023	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	62230000	usd
CY2022	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	-44537000	usd
CY2021	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	-8193000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4040000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	usd
CY2023	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	-493000	usd
CY2022	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	0	usd
CY2021	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	0	usd
CY2023	newt	Increase Decrease In Due From Due To Related Parties IncreaseDecreaseInDueFromDueToRelatedParties	-165000	usd
CY2022	newt	Increase Decrease In Due From Due To Related Parties IncreaseDecreaseInDueFromDueToRelatedParties	2778000	usd
CY2021	newt	Increase Decrease In Due From Due To Related Parties IncreaseDecreaseInDueFromDueToRelatedParties	677000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7432000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1816000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-800000	usd
CY2023	newt	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	4776000	usd
CY2022	newt	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	0	usd
CY2021	newt	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	0	usd
CY2023	newt	Increase Decrease In Due To Participants IncreaseDecreaseInDueToParticipants	-11832000	usd
CY2022	newt	Increase Decrease In Due To Participants IncreaseDecreaseInDueToParticipants	-110598000	usd
CY2021	newt	Increase Decrease In Due To Participants IncreaseDecreaseInDueToParticipants	128340000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22552000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9021000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1194000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	6000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	23000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-169219000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-62418000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	140923000	usd
CY2023	newt	Payments To Acquire Loans Held For Investment At Fair Value PaymentsToAcquireLoansHeldForInvestmentAtFairValue	-29349000	usd
CY2022	newt	Payments To Acquire Loans Held For Investment At Fair Value PaymentsToAcquireLoansHeldForInvestmentAtFairValue	0	usd
CY2021	newt	Payments To Acquire Loans Held For Investment At Fair Value PaymentsToAcquireLoansHeldForInvestmentAtFairValue	0	usd
CY2023	newt	Proceeds From Loans Held For Investment At Cost ProceedsFromLoansHeldForInvestmentAtCost	-169003000	usd
CY2022	newt	Proceeds From Loans Held For Investment At Cost ProceedsFromLoansHeldForInvestmentAtCost	0	usd
CY2021	newt	Proceeds From Loans Held For Investment At Cost ProceedsFromLoansHeldForInvestmentAtCost	0	usd
CY2023	newt	Payments For Contributions To Joint Ventures PaymentsForContributionsToJointVentures	14550000	usd
CY2022	newt	Payments For Contributions To Joint Ventures PaymentsForContributionsToJointVentures	0	usd
CY2021	newt	Payments For Contributions To Joint Ventures PaymentsForContributionsToJointVentures	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	458000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	564000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2023	us-gaap	Increase Decrease In Loans To Federal Home Loan Banks IncreaseDecreaseInLoansToFederalHomeLoanBanks	2112000	usd
CY2022	us-gaap	Increase Decrease In Loans To Federal Home Loan Banks IncreaseDecreaseInLoansToFederalHomeLoanBanks	0	usd
CY2021	us-gaap	Increase Decrease In Loans To Federal Home Loan Banks IncreaseDecreaseInLoansToFederalHomeLoanBanks	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184006000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125606000	usd
CY2023	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	2978000	usd
CY2022	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	3466000	usd
CY2021	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	2171000	usd
CY2023	newt	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	4363000	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-11142000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-172235000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-78663000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	5885000	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-36339000	usd
CY2023	newt	Increase Decrease In Deposit Liabilities IncreaseDecreaseInDepositLiabilities	324705000	usd
CY2022	newt	Increase Decrease In Deposit Liabilities IncreaseDecreaseInDepositLiabilities	0	usd
CY2021	newt	Increase Decrease In Deposit Liabilities IncreaseDecreaseInDepositLiabilities	0	usd
CY2023	newt	Repayment Of Federal Home Loan Bank Advances RepaymentOfFederalHomeLoanBankAdvances	4895000	usd
CY2022	newt	Repayment Of Federal Home Loan Bank Advances RepaymentOfFederalHomeLoanBankAdvances	0	usd
CY2021	newt	Repayment Of Federal Home Loan Bank Advances RepaymentOfFederalHomeLoanBankAdvances	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2019000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50007000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	19493000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	12800000	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-12640000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	90780000	usd
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	103430000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	64544000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	70144000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4650000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2552000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5295000	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	51000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	826000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1575000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	344974000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1175000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5488000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3520000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61254000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	135435000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125606000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186860000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51425000	usd
CY2023Q4	newt	Consolidation Of Cash From Investments ConsolidationOfCashFromInvestments	54880000	usd
CY2022Q4	newt	Consolidation Of Cash From Investments ConsolidationOfCashFromInvestments	0	usd
CY2021Q4	newt	Consolidation Of Cash From Investments ConsolidationOfCashFromInvestments	0	usd
CY2022	newt	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	2118000	usd
CY2021	newt	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	219000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	1614000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	1923000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	9108000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	18344000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	20131000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6884000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q2	newt	Sba Obligations Secured Fund SBAObligationsSecuredFund	10000000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts, to the extent comparable, have been reclassified to conform to the current period presentation.</span></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expense during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are complete. Actual results could differ from those estimates.</span></div>
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	37200000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	30900000	usd
CY2023Q4	us-gaap	Cash Cash	15398000	usd
CY2022Q4	us-gaap	Cash Cash	53692000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	30919000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	71914000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	137689000	usd
CY2022Q4	us-gaap	Due From Banks DueFromBanks	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184006000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125606000	usd
CY2023	newt	Financing Receivable Weighted Average Life FinancingReceivableWeightedAverageLife	P5Y
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	1200000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Allowance for Credit Losses – Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“CECL”) approach requires an estimate of the credit losses expected over the life of a loan (or pool of loans). The allowance for credit losses is a valuation account that is deducted from the loans’ amortized cost basis to present the net, lifetime amount expected to be collected on the loans. Loan losses are charged off against the allowance when management believes a loan balance is uncollectible. Expected recoveries do not exceed the aggregate of amounts previously charged-off and expected to be charged-off.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The allowance is comprised of reserves measured on a collective (pool) basis based on a lifetime loss-rate model when similar risk characteristics exist. Loans that do not share risk characteristics are evaluated on an individual basis, which generally includes larger non-accruing commercial loans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The discounted cash flow (“DCF”) method is used to estimate expected credit losses for all loan portfolio segments measured on a collective (pool) basis. For each loan segment, cash flow projections are generated at the instrument level wherein payment expectations are adjusted for estimated prepayment speeds, probability of default, and loss given default. The modeling of prepayment speeds is based on a combination of historical internal data and peer data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Regression analysis of historical internal and peer data is used to determine suitable loss drivers to utilize when modeling lifetime probability of default. This analysis also determines how expected probability of default and loss given default will react to forecasted levels of the loss drivers. The SBA 7(a) loan portfolio is the single loan pool where management solely utilizes historical internal data to determine the loss rate as an input to the model. The data utilized represents the most recent economic cycle and management determines the loss rate by analyzing defaulted principal and net charge offs to calculate the historical loss rate. For all loan pools utilizing the DCF method, management utilizes various economic indicators such as changes in unemployment rates, gross domestic product, real estate values, and other relevant factors as loss drivers. For all DCF models, management has determined that due to historic volatility in economic data, four quarters currently represents a reasonable and supportable forecast period, followed by a four-quarter reversion to historical mean levels for each of the various economic indicators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The combination of adjustments for credit expectations (default and loss) and timing expectations (prepayment, curtailment, and time to recovery) produces an expected cash flow stream at the instrument level. Specific instrument effective yields are calculated, net of the impacts of prepayment assumptions, and the instrument expected cash flows are then discounted at that effective yield to produce an instrument-level Net Present Value (“NPV”). An allowance is established for the difference between the instrument’s NPV and amortized cost basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The allowance evaluation also considers various qualitative factors, such as: (i) changes to lending policies, underwriting standards and/or management personnel performing such functions, (ii) delinquency and other credit quality trends, (iii) credit risk concentrations, if any, (iv) changes to the nature of the Company's business impacting the loan portfolio, and (v) other external factors, that may include, but are not limited to, results of internal loan reviews, stress testing, examinations by bank regulatory agencies, or other events such as a natural disaster. Significant management judgment is required at each point in the measurement process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Arriving at an appropriate level of allowance involves a high degree of judgment. The determination of the adequacy of the allowance and provisioning for estimated losses is evaluated regularly based on review of loans, with particular emphasis on non-performing and other loans that management believes warrant special consideration. While management uses available information to recognize losses on loans, changing economic conditions and the economic prospects of the borrowers may necessitate future additions or reductions to the allowance. Management estimates the allowance balance using relevant available information, from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. The Company’s historical credit loss experience provides the basis for the estimation of expected credit losses, supplemented with peer loss information, and results in expected probabilities of default and expected losses given default. Adjustments to historical loss information are made for differences in current loan-specific risk characteristics such as differences in underwriting standards, portfolio mix, delinquency level, or term as well as changes in environmental conditions, such as changes in unemployment rates, production metrics, property values, or other relevant factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Expected losses are applied to loans grouped in portfolio segments, which are pools of loans aggregated based on type of borrower and collateral which is generally based upon federal call report segmentation. Portfolio segments have been combined or sub-segmented as needed to ensure loans of similar risk profiles are appropriately pooled. These portfolio segments are as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Commercial Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The commercial real estate portfolio is comprised of loans to borrowers on small offices, owner-occupied commercial buildings, industrial/warehouse properties, income producing/investor real estate properties, and multi-family loans secured by first mortgages. The Company’s underwriting standards generally target a loan-to-value ratio of 75%, depending on the type of collateral, and requires debt service coverage of a minimum of 1.2 times.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Commercial & Industrial:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The commercial & industrial portfolio consists of loans made for general business purposes consisting of short-term working capital loans, equipment loans and unsecured business lines. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">SBA 7(a):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The SBA 7(a) portfolio includes loans originated under the federal Section 7(a) loan program. The SBA is an independent government agency that facilitates one of the nation’s largest sources of SMB financing by providing credit guarantees for its loan programs. SBA 7(a) loans are partially guaranteed by the SBA, with SBA guarantees typically ranging between 50% and 90% of the principal and interest due. Under the SBA’s 7(a) lending program, a bank or other lender may underwrite loans between $5,000 and $5.0 million for a variety of general business purposes based on the SBA’s loan program requirements. The guaranteed portion of the loans are held for sale and carried at LCM and therefore are not subject to CECL. The unguaranteed portion of the loans that are held on balance sheet at amortized cost are subject to CECL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Individually Evaluated Loans: Loans that do not share risk characteristics with existing pools are evaluated on an individual basis. For loans that are individually evaluated and collateral dependent, financial loans where management has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and management expects repayment of the financial asset to be provided substantially through the sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral and the amortized cost basis of the asset as of the measurement date. When repayment is expected to be from the operation of the collateral or going concern, the specific credit loss reserve is calculated as the amount by which the amortized cost basis of the financial asset exceeds the NPV from the operation of the collateral. When repayment is expected to be from the sale of the collateral, the specific credit loss reserve is calculated as the amount by which the amortized costs basis of the financial asset exceeds the fair value of the underlying collateral less estimated cost to sell. The allowance may be zero if the fair value of the collateral at the measurement date exceeds the amortized cost basis of the financial asset.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Accrued Interest. Accrued interest receivable balances are presented within other assets on the consolidated balance sheet. Accrued interest is excluded from the measurement of the allowance for credit losses, including investments and loans. Generally, accrued interest is reversed when a loan is placed on non-accrual or is written-off. Current year accrued interest is reversed through interest income while accrued interest from prior years is written-off through the ACL. Historically, we have not experienced uncollectible accrued interest receivable on investment debt securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Allowance for off-balance sheet credit exposures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The exposure is a component of other liabilities in the consolidated balance sheet and represents the estimate for probable credit losses inherent in unfunded commitments to extend credit. Unfunded commitments to extend credit include unused portions of lines of credit and standby and commercial letters of credit. The process used to determine the allowance for these exposures is consistent with the process for determining the allowance for loans, as adjusted for estimated funding probabilities or loan equivalency factors. A charge (credit) to provision for credit losses on the consolidated statements of income is made to account for the change in the allowance on off-balance sheet exposures between reporting periods.</span></div>
CY2023Q4	newt	Financing Receivable Loan To Value Ratio FinancingReceivableLoanToValueRatio	0.75
CY2023Q4	newt	Debt Instrument Service Coverage Ratio Minimum DebtInstrumentServiceCoverageRatioMinimum	1.2
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	0	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1000000	usd
CY2023	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2023	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2023Q4	newt	Number Of Sponsor Banks NumberOfSponsorBanks	2	sponsorbank
CY2023Q4	newt	Number Of Merchant Processors NumberOfMerchantProcessors	1	merchantprocessor
CY2023	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	564000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5200000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	19200000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	248000	usd
CY2023	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2023	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023	newt	Interest And Other Income Operating InterestAndOtherIncomeOperating	0	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	1641000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	6435000	usd
CY2023	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	14302000	usd
CY2023	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2023	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	722000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	21459000	usd
CY2023	newt	Interest And Other Income Operating InterestAndOtherIncomeOperating	0	usd
CY2023	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-68000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	368000	usd
CY2023	newt	Interest And Other Income Operating InterestAndOtherIncomeOperating	0	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	116000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	360000	usd
CY2023	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2023	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2023	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	0	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	360000	usd
CY2023	newt	Interest And Other Income Operating InterestAndOtherIncomeOperating	0	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	32372000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	201000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	32171000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	200000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	32171000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	201000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	3	loan
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	32171000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	201000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	32372000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	32171000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	32372000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	32171000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	0	usd
CY2023Q4	newt	Pledged Financial Instruments Not Separately Reported Debt Securities Available For Sale PledgedFinancialInstrumentsNotSeparatelyReportedDebtSecuritiesAvailableForSale	30730000	usd
CY2022Q4	newt	Pledged Financial Instruments Not Separately Reported Debt Securities Available For Sale PledgedFinancialInstrumentsNotSeparatelyReportedDebtSecuritiesAvailableForSale	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost Industry Loans FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostIndustryLoans	482563000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Industry Loans FinancingReceivableBeforeAllowanceForCreditLossFairValueIndustryLoans	469801000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost Industry Loans FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostIndustryLoans	532793000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Industry Loans FinancingReceivableBeforeAllowanceForCreditLossFairValueIndustryLoans	505268000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	393000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss After Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossAfterDeferredLoanFees	336305000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss After Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossAfterDeferredLoanFees	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	393000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	393000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost And Fair Value FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostAndFairValue	793532000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	505268000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	505268000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	5300000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	100000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2022Q4	newt	Financing Receivable Allowance For Credit Loss Adjusted Opening Balance FinancingReceivableAllowanceForCreditLossAdjustedOpeningBalance	870000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1500000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	11704000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Before Deferred Fees And Costs FinancingReceivableHeldForSaleBeforeDeferredFeesAndCosts	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Before Deferred Fees And Costs FinancingReceivableHeldForSaleLowerOfCostOrMarketBeforeDeferredFeesAndCosts	55829000	usd
CY2022Q4	newt	Financing Receivable Held For Sale Before Deferred Fees And Costs FinancingReceivableHeldForSaleBeforeDeferredFeesAndCosts	19171000	usd
CY2022Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Before Deferred Fees And Costs FinancingReceivableHeldForSaleLowerOfCostOrMarketBeforeDeferredFeesAndCosts	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSale	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale Lower Of Cost Or Market FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSaleLowerOfCostOrMarket	778000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSale	0	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale Lower Of Cost Or Market FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSaleLowerOfCostOrMarket	0	usd
CY2023Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	56607000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	19171000	usd
CY2022Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	0	usd
CY2023Q4	us-gaap	Servicing Asset ServicingAsset	39725000	usd
CY2022Q4	us-gaap	Servicing Asset ServicingAsset	30268000	usd
CY2023	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	18300000	usd
CY2022	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	13700000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	25885000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q1	newt	Goodwill Acquired Upon Consolidation Of Company GoodwillAcquiredUponConsolidationOfCompany	300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16140000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11905000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4235000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	655000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	622000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	601000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	580000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	560000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1217000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4235000	usd
CY2023Q4	us-gaap	Other Real Estate OtherRealEstate	1110000	usd
CY2023Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	29336000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	692872000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	630000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	771000	usd
CY2022Q4	us-gaap	Other Real Estate OtherRealEstate	3529000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	30268000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	841835000	usd
CY2023Q4	us-gaap	Cash Cash	15398000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	30919000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	137689000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	32171000	usd
CY2023Q4	newt	Marketable Securities Fair Value Disclosure MarketableSecuritiesFairValueDisclosure	32171000	usd
CY2023Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Fair Value Disclosure FinancingReceivableHeldForSaleFairValueDisclosure	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	56607000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Fair Value Disclosure FinancingReceivableHeldForSaleLowerOfCostOrMarketFairValueDisclosure	56733000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2023Q4	newt	Financing Receivable Fair Value Disclosure FinancingReceivableFairValueDisclosure	337133000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	3635000	usd
CY2023Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	3635000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	167041000	usd
CY2023Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	168542000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	644122000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	641794000	usd
CY2022Q4	us-gaap	Cash Cash	53692000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	71914000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	19171000	usd
CY2022Q4	newt	Financing Receivable Held For Sale Fair Value Disclosure FinancingReceivableHeldForSaleFairValueDisclosure	19171000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	505268000	usd
CY2022Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	505268000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	539326000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	540388000	usd
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	10053000	usd
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	0	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Checking InterestBearingDomesticDepositChecking	11456000	usd
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Checking InterestBearingDomesticDepositChecking	0	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	15803000	usd
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	0	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	259152000	usd
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	0	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	167041000	usd
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	0	usd
CY2023Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	453452000	usd
CY2022Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	0	usd
CY2023Q4	us-gaap	Deposits Deposits	463505000	usd
CY2022Q4	us-gaap	Deposits Deposits	0	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	53548000	usd
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	0	usd
CY2023Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	66511000	usd
CY2022Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	0	usd
CY2023Q4	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	53000	usd
CY2022Q4	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	0	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	54805000	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	63402000	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	28379000	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	19710000	usd
CY2023Q4	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	745000	usd
CY2023Q4	us-gaap	Time Deposit Maturities After Year Five TimeDepositMaturitiesAfterYearFive	0	usd
CY2023Q4	us-gaap	Time Deposits TimeDeposits	167041000	usd
CY2023Q4	newt	Loan Related Remittances LoanRelatedRemittances	3577000	usd
CY2022Q4	newt	Loan Related Remittances LoanRelatedRemittances	70000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1349000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3051000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4114000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2846000	usd
CY2023Q4	newt	Accrued Funds In Process To Payroll Customers AccruedFundsInProcessToPayrollCustomers	5060000	usd
CY2022Q4	newt	Accrued Funds In Process To Payroll Customers AccruedFundsInProcessToPayrollCustomers	0	usd
CY2023Q4	newt	Loan Related Accruals LoanRelatedAccruals	3793000	usd
CY2022Q4	newt	Loan Related Accruals LoanRelatedAccruals	2059000	usd
CY2023Q4	newt	Loan Repair And Denial Reserve LoanRepairAndDenialReserve	3063000	usd
CY2022Q4	newt	Loan Repair And Denial Reserve LoanRepairAndDenialReserve	0	usd
CY2023Q4	newt	Good Faith Deposits GoodFaithDeposits	893000	usd
CY2022Q4	newt	Good Faith Deposits GoodFaithDeposits	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	15451000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	13398000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	37300000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	21424000	usd
CY2023Q4	newt	Debt Instrument Maximum Borrowing Capacity Amount Outstanding DebtInstrumentMaximumBorrowingCapacityAmountOutstanding	878235000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	644122000	usd
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0704
CY2022Q4	newt	Debt Instrument Maximum Borrowing Capacity Amount Outstanding DebtInstrumentMaximumBorrowingCapacityAmountOutstanding	666393000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	539326000	usd
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0611
CY2023Q4	us-gaap	Federal Home Loan Bank Advances Valuation Adjustments Under Fair Value Option FederalHomeLoanBankAdvancesValuationAdjustmentsUnderFairValueOption	-200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	117094000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	41985000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	40000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	53109000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	104701000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7502000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	296223000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	653112000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-699000	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	834000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	183000	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	445000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-183000	usd
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	590000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2761000	usd
CY2023Q4	newt	Employment Agreement To Be Paid Year One EmploymentAgreementToBePaidYearOne	525000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	3286000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2469000	usd
CY2023Q4	newt	Employment Agreement To Be Paid Year Two EmploymentAgreementToBePaidYearTwo	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	2469000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1842000	usd
CY2023Q4	newt	Employment Agreement To Be Paid Year Three EmploymentAgreementToBePaidYearThree	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	1842000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	430000	usd
CY2023Q4	newt	Employment Agreement To Be Paid Year Four EmploymentAgreementToBePaidYearFour	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	430000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	newt	Employment Agreement To Be Paid Year Five EmploymentAgreementToBePaidYearFive	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	newt	Employment Agreement To Be Paid After Year Five EmploymentAgreementToBePaidAfterYearFive	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	usd
CY2023Q4	newt	Employment Agreement To Be Paid EmploymentAgreementToBePaid	525000	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	8027000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2800000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2500000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	47540	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.03468
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1500000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2023Q2	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.18
CY2023Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	4291000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	6000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	72000	usd
CY2023Q3	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.18
CY2023Q3	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	4293000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	4000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	73000	usd
CY2023Q4	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.18
CY2023Q4	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	4293000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	6000	shares
CY2023Q4	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	71000	usd
CY2022Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.65
CY2022Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	15361000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	9000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	225000	usd
CY2022Q2	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.75
CY2022Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	17634000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	21000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	374000	usd
CY2022Q3	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.65
CY2022Q3	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	15325000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	21000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	323000	usd
CY2022Q4	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.70
CY2022Q4	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	16224000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	45000	shares
CY2022Q4	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	692000	usd
CY2023Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	180829000	usd
CY2023Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.136
CY2023Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	53363000	usd
CY2023Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.040
CY2023Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	180829000	usd
CY2023Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.162
CY2023Q4	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	50153000	usd
CY2023Q4	us-gaap	Banking Regulation Common Equity Tier One Risk Based Capital Ratio Capital Adequacy Minimum BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioCapitalAdequacyMinimum	0.045
CY2023Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	180829000	usd
CY2023Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.162
CY2023Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	66870000	usd
CY2023Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.060
CY2023Q4	us-gaap	Capital Capital	213141000	usd
CY2023Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.191
CY2023Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	89160000	usd
CY2023Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.080
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	45875000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	32311000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	84142000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24263000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24198000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22795000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.69
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	45875000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	32311000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	84142000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24263000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24198000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22795000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	85000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24348000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24198000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22795000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.69
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	35400000	usd
CY2023	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	1153000	usd
CY2022	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2021	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2693000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1886000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1555000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M17D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M28D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0473
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0455
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	3124000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1000000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	894000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2761000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2469000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1842000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	430000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7502000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	550000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6952000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2022	newt	Defined Contribution Plan Employer Matching Contribution Percent Of Match Of Employee Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOfEmployeeContributions	0.02
CY2023	newt	Defined Contribution Plan Employer Matching Contribution Percent Of Match Of Employee Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOfEmployeeContributions	0.02
CY2021	newt	Defined Contribution Plan Employer Matching Contribution Percent Of Match Of Employee Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOfEmployeeContributions	0.02
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	400000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0431
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1251000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1593000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2844000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4318000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-482000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4800000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1956000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9528000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	911000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	788000	usd
CY2023	newt	Effective Income Tax Rate Reconciliation Realization Of Operating Loss Carryforwards Amount EffectiveIncomeTaxRateReconciliationRealizationOfOperatingLossCarryforwardsAmount	-7430000	usd
CY2023	newt	Effective Income Tax Reconciliation Change In Taxpayer Status EffectiveIncomeTaxReconciliationChangeInTaxpayerStatus	-5550000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-203000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1956000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0431
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3313000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	0	usd
CY2023Q4	newt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	1832000	usd
CY2022Q4	newt	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1669000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2023Q4	newt	Deferred Tax Assets Purchase Accounting Net DeferredTaxAssetsPurchaseAccountingNet	331000	usd
CY2022Q4	newt	Deferred Tax Assets Purchase Accounting Net DeferredTaxAssetsPurchaseAccountingNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	396000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	0	usd
CY2023Q4	newt	Deferred Tax Assets Financing Receivable DeferredTaxAssetsFinancingReceivable	2677000	usd
CY2022Q4	newt	Deferred Tax Assets Financing Receivable DeferredTaxAssetsFinancingReceivable	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2428000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12646000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	650000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	19194000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Mortgage Servicing Rights DeferredTaxLiabilitiesMortgageServicingRights	2737000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Mortgage Servicing Rights DeferredTaxLiabilitiesMortgageServicingRights	0	usd
CY2023Q4	newt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1502000	usd
CY2022Q4	newt	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2330000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	197000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7416000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	19194000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5230000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	19194000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	94373000	usd
CY2023	us-gaap	Interest Expense InterestExpense	67739000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26634000	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	11704000	usd
CY2023	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	14930000	usd
CY2023	us-gaap	Noninterest Income NoninterestIncome	176772000	usd
CY2023	us-gaap	Noninterest Expense NoninterestExpense	146329000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	45373000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1956000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	47329000	usd
CY2023Q4	us-gaap	Assets Assets	1429513000	usd
CY2023Q3	us-gaap	Cash Cash	223692000	usd
CY2023Q2	us-gaap	Cash Cash	256333000	usd
CY2023Q1	us-gaap	Cash Cash	197143000	usd
CY2023Q3	us-gaap	Notes Receivable Net NotesReceivableNet	273378000	usd
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	213795000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	164648000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	31311000	usd
CY2023Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	31667000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	32091000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16255000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12627000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12826000	usd
CY2023Q3	us-gaap	Servicing Asset ServicingAsset	38291000	usd
CY2023Q2	us-gaap	Servicing Asset ServicingAsset	36238000	usd
CY2023Q1	us-gaap	Servicing Asset ServicingAsset	33679000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	49848000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	48211000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	51479000	usd
CY2023Q3	newt	All Other Assets AllOtherAssets	760720000	usd
CY2023Q2	newt	All Other Assets AllOtherAssets	852150000	usd
CY2023Q1	newt	All Other Assets AllOtherAssets	767933000	usd
CY2023Q3	us-gaap	Assets Assets	1393495000	usd
CY2023Q2	us-gaap	Assets Assets	1451021000	usd
CY2023Q1	us-gaap	Assets Assets	1259799000	usd
CY2023Q3	us-gaap	Deposits Deposits	432559000	usd
CY2023Q2	us-gaap	Deposits Deposits	447357000	usd
CY2023Q1	us-gaap	Deposits Deposits	247574000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	36671000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	37674000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	44912000	usd
CY2023Q3	newt	All Other Liabilities AllOtherLiabilities	682063000	usd
CY2023Q2	newt	All Other Liabilities AllOtherLiabilities	730541000	usd
CY2023Q1	newt	All Other Liabilities AllOtherLiabilities	734727000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1151293000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1215572000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1027213000	usd
CY2023Q3	newt	All Other Equity Attributable To Parent AllOtherEquityAttributableToParent	20045000	usd
CY2023Q2	newt	All Other Equity Attributable To Parent AllOtherEquityAttributableToParent	20026000	usd
CY2023Q1	newt	All Other Equity Attributable To Parent AllOtherEquityAttributableToParent	20147000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	22202000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16065000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13879000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	199955000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	199358000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	198560000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	242202000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	235449000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	232586000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1393495000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1451021000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1259799000	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	26736000	usd
CY2023Q2	us-gaap	Interest Income Operating InterestIncomeOperating	22553000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	18715000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	18659000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	16880000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	14132000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8077000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5673000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4583000	usd
CY2023Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3446000	usd
CY2023Q2	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2575000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1318000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	13751000	usd
CY2023Q2	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	13364000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	6367000	usd
CY2023Q3	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	5376000	usd
CY2023Q2	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	6371000	usd
CY2023Q1	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	6709000	usd
CY2023Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	21897000	usd
CY2023Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther	24550000	usd
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	29280000	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13726000	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	18374000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	19073000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	730000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	750000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	791000	usd
CY2023Q3	newt	Loan Processing Fee Other LoanProcessingFeeOther	1836000	usd
CY2023Q2	newt	Loan Processing Fee Other LoanProcessingFeeOther	2313000	usd
CY2023Q1	newt	Loan Processing Fee Other LoanProcessingFeeOther	2781000	usd
CY2023Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	15028000	usd
CY2023Q2	us-gaap	Other Noninterest Expense OtherNoninterestExpense	16340000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	16378000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3416000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2595000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11952000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	10919000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	7011000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	18550000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24277000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24264000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24223000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24413000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24306000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24881000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
	us-gaap	Interest Income Operating InterestIncomeOperating	68004000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	41268000	usd
	us-gaap	Interest Expense InterestExpense	49671000	usd
	us-gaap	Interest Expense InterestExpense	31012000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18333000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10256000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	7339000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3893000	usd
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	33482000	usd
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	19731000	usd
	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	18456000	usd
	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	13080000	usd
	us-gaap	Noninterest Income Other NoninterestIncomeOther	75727000	usd
	us-gaap	Noninterest Income Other NoninterestIncomeOther	53830000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	51173000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	37447000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2271000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1541000	usd
	newt	Loan Processing Fee Other LoanProcessingFeeOther	6930000	usd
	newt	Loan Processing Fee Other LoanProcessingFeeOther	5094000	usd
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	47746000	usd
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	32718000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5941000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9357000	usd
	us-gaap	Net Income Loss NetIncomeLoss	36480000	usd
	us-gaap	Net Income Loss NetIncomeLoss	25561000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24255000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24244000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24336000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24298000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2023Q2	newt	Sba Obligations Secured Fund SBAObligationsSecuredFund	10000000	usd

Files In Submission

Name	View Source	Status
0001587987-24-000054-index-headers.html	Edgar Link	pending
0001587987-24-000054-index.html	Edgar Link	pending
0001587987-24-000054.txt	Edgar Link	pending
0001587987-24-000054-xbrl.zip	Edgar Link	pending
consentofindependentaudi.htm	Edgar Link	pending
consentofindependentaudi001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
formofchangeincontrolagr.htm	Edgar Link	pending
formofchangeincontrolagr001.jpg	Edgar Link	pending
formofchangeincontrolagr002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
formofchangeincontrolagr003.jpg	Edgar Link	pending
formofchangeincontrolagr004.jpg	Edgar Link	pending
formofchangeincontrolagr005.jpg	Edgar Link	pending
formofchangeincontrolagr006.jpg	Edgar Link	pending
formofchangeincontrolagr007.jpg	Edgar Link	pending
formofrestrictedstockawa.htm	Edgar Link	pending
formofrestrictedstockawa001.jpg	Edgar Link	pending
formofrestrictedstockawa002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
newt-123123exh211listofsubs.htm	Edgar Link	pending
newt-123123xexh311.htm	Edgar Link	pending
newt-123123xexh312.htm	Edgar Link	pending
newt-123123xexh321.htm	Edgar Link	pending
newt-123123xexh322.htm	Edgar Link	pending
newt-123123xexh42descripti.htm	Edgar Link	pending
newt-20231231.htm	Edgar Link	pending
newt-20231231.xsd	Edgar Link	pending
newt-20231231_g1.jpg	Edgar Link	pending
newtekoneclawbackpolicy-.htm	Edgar Link	pending
newtekoneclawbackpolicy-001.jpg	Edgar Link	pending
newtekoneclawbackpolicy-002.jpg	Edgar Link	pending
newtekoneclawbackpolicy-003.jpg	Edgar Link	pending
newtekoneclawbackpolicy-004.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
newt-20231231_def.xml	Edgar Link	unprocessable
newt-20231231_lab.xml	Edgar Link	unprocessable
newt-20231231_pre.xml	Edgar Link	unprocessable
newt-20231231_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
newt-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEWT
NewtekOne, Inc. Stock $newt

2024 Q1 Form 10-K Financial Statement

#000158798724000054 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEWT NewtekOne, Inc. Stock $newt

2024 Q1 Form 10-K Financial Statement

#000158798724000054 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEWT
NewtekOne, Inc. Stock $newt